Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$245,715
-$24,020 QoQ
Shares Held
4,516
-28.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#554
of 751 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Flatrock Wealth Partners LLC holds $477,671 across 2 Biotechnology names. EXEL ranks #1 (51.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
4,516 | $245,715 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
372 | $231,956 |
All Filings in EXEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,715 | 4,516 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $269,735 | 6,289 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $333,414 | 7,607 | Shares | Sole | 2026-05-26 | |
| No filing history on record for this holder in this stock. | ||||||